Companies / Inhibrx, Inc.
Inhibrx, Inc.
INBXCIK 1739614
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 30, 2024 | Viking Global Investors LP 10% owner | Other Other (per filing) | Common Stock | $189.18M | -6.3M -100.00% | 0 | low |
| May 30, 2024 | Kayyem Jon Faiz Director | Other Sold to issuer | Common Stock | $96.73M | -3.2M -100.00% | 0 | low |
| May 30, 2024 | Mark Lappe CEO | Other Sold to issuer | Common Stock | $74.59M | -2.5M -100.00% | 0 | low |
| May 30, 2024 | Eckelman Brendan P. Executive | Other Sold to issuer | Common Stock | $52.07M | -1.7M -100.00% | 0 | low |
| Oct 7, 2022 | Viking Global Investors LP 10% owner | Buy Open-market buy | Common Stock | $30.00M | +1.0M +70.06% | 2,427,307 | high |
| May 30, 2024 | Forsyth Douglas Director | Other Sold to issuer | Common Stock | $17.95M | -598K -100.00% | 0 | low |
| May 30, 2024 | Viking Global Investors LP 10% owner | Other Other (per filing) | Common Stock | $15.35M | -512K -100.00% | 0 | low |
| May 30, 2024 | Mark Lappe CEO | Other Sold to issuer | Common Stock | $15.00M | -500K -100.00% | 0 | low |